Minzhang Chen

Chief Executive Officer, WuXi STA

Minzhang Chen joined WuXi AppTec in 2008 and currently serves as CEO of WuXi STA, the small molecule process development and manufacturing subsidiary of WuXi AppTec. Under his leadership, WuXi STA has grown from an early phase process research focused organization to a world leading contract development and manufacturing organization for small molecule APIs and finished dosage forms from preclinical to commercial. Prior to joining WuXi, he served as Director of Technical Operations at Vertex Pharmaceuticals where he led a team who successfully supported the process R&D, API contract manufacturing and commercialization of Incivek.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019